Acumen PharmaceuticalsABOS

那斯達克 · USD
2.24
+0.05
(+2.28%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
21,14925,19926,51341,75030,370--24,381--
研發費用
16,48420,52621,96837,12525,26634,56927,24719,53312,44913,293
推銷及管理費用
4,6654,6734,5454,6255,1045,0285,0184,8485,3255,193
非經常性項目費用
----------
其他營業費用
----------
營業利益
-21,149
-25,199
-26,513
-41,750
-30,370
-39,597
-32,265
-24,381
-17,774
-18,486
其他收入及費用
1,4811,1481,1301,8462,5973,4803,5274,8483,9012,570
利息費用
1,0691,0871,0681,0461,0231,0371,0271,0041,000581
稅前純益
-20,737
-25,138
-26,451
-40,950
-28,796
-37,154
-29,765
-20,537
-14,873
-16,497
所得稅
----------
稅後純益
-20,737
-25,138
-26,451
-40,950
-28,796
-37,154
-29,765
-20,537
-14,873
-16,497
基本每股稅後盈餘(元)
-0.33-0.40-0.44-0.68-0.48-0.62-0.50-0.34-0.25-
稀釋每股稅後盈餘(元)
-0.33-0.41-0.44-0.67-0.48-0.62-0.50-0.34-0.25-0.29
基本平均股數(千股)
63219.0060576.0060573.0060573.0060525.0060083.0060079.0060079.0059812.00-
稀釋平均股數(千股)
63219.0060576.0060573.0060573.0060525.0060083.0060079.0060079.0059812.00-
還原基本每股稅後盈餘(元)
-0.33-0.40-0.44-0.68-0.48-0.62-0.50-0.34-0.25-
還原稀釋每股稅後盈餘(元)
-0.33-0.41-0.44-0.67-0.48-0.62-0.50-0.34-0.25-0.29
還原基本平均股數(千股)
63,21960,57660,57360,57360,52560,08360,07960,07959,812-
還原稀釋平均股數(千股)
63,21960,57660,57360,57360,52560,08360,07960,07959,812-
EBITDA(千元)
-19,597-23,896-25,611-39,913-28,316-36,489-30,070-20,947-15,592-17,654

大家都在看

HOT